First-line chemotherapy for metastatic breast cancer in high-risk patients- Greater therapeutic effect with mitoxantron monotherapy than with combination therapy with 5-fluorouracil, epirubicin and cyclophosphamide

Heidemann, E Stoeger, H Souchon, R Hirschmann, WD Bodenstein, H Oberhoff, C Fischer, JT Schulze, M Clemens, M Andreesen, R Mahlke, M Konig, M Scharl, A Gruener, A Fehnle, K Kaufmann, M

E. Heidemann et al., First-line chemotherapy for metastatic breast cancer in high-risk patients- Greater therapeutic effect with mitoxantron monotherapy than with combination therapy with 5-fluorouracil, epirubicin and cyclophosphamide, ONKOLOGIE, 23(3), 2000, pp. 2-4

8

Oncology

ONKOLOGIE

0378584X → ACNP

23

3

2000

2 - 4

ISI

0378-584X(200006)23:3<2:FCFMBC>2.0.ZU;2-3